SCHEMBL19981940

SCHEMBL19981940

CCCN(CCC)C(=O)[C@@H](N)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.44
CA12 O43570 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
SLC7A5 Q01650 1/20 0.41
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
TP53 P04637 1/20 0.35
DPP8 Q6V1X1 2/20 0.35
DPP9 Q86TI2 2/20 0.35
DPP7 Q9UHL4 2/20 0.35
CA1 P00915 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
P2RX1 P51575 2/20 0.32
P2RX4 Q99571 2/20 0.32
P2RX3 P56373 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19981632 0.88 CA12 (0.45) DPP4CA12CA2CA9SLC7A5
SCHEMBL9537159 0.86 DPP4 (0.41) DPP4CA12CA2CA9SLC7A5
SCHEMBL9537149 0.86 DPP4 (0.41) DPP4CA12CA2CA9SLC7A5
Hydrochloric Acid SCHEMBL9439468 0.84 DPP4 (0.40) DPP4CA12CA2CA9SLC7A5
Hydrochloric Acid SCHEMBL9439130 0.84 DPP4 (0.40) DPP4CA12CA2CA9SLC7A5
SCHEMBL1619583 0.82 DPP4 (0.47) DPP4SLC7A5ALDH1A1DPP8DPP9
SCHEMBL6201950 0.82 CA12 (0.44) DPP4CA12CA2CA9TSHR
SCHEMBL9873959 0.82 CA12 (0.44) DPP4CA12CA2CA9TSHR
SCHEMBL1619585 0.82 DPP4 (0.47) DPP4SLC7A5ALDH1A1DPP8DPP9
SCHEMBL9462283 0.77 CA12 (0.48) CA12CA2CA9TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11292783-B2 Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists RESEARCH TRIANGLE INSTITUTE (NC) 2022-04-05 US disclosed
EP-3512832-B1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RES TRIANGLE INST (US) 2021-05-19 EP disclosed
US-20190263781-A1 Tetrahydroisoquinoline Kappa Opioid Antagonists RESEARCH TRIANGLE INSTITUTE (US) 2019-08-29 US disclosed
WO-2018053222-A1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RESEARCH TRAINGLE INSTITUTE (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11292783-B2 Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists OPRK1, OPRD1, OPRM1 DPP4 3504/4885CA12 4417/4885CA2 4676/4885
US-20190263781-A1 Tetrahydroisoquinoline Kappa Opioid Antagonists OPRK1, OPRD1, OPRM1 DPP4 3757/4885CA12 4380/4885CA2 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.